VASCULARITY TARGETED PERCUTANEOUS ETHANOL INJECTION OF TOXIC ADENOMAS: OUTCOMES OF A FEASIBILITY STUDY PERFORMED IN THE USA.
Abstract Objective: The recommended treatment options for toxic adenomas (TA) in the USA are radioactive iodine ablation and surgical resection, and continued observation for pre-toxic adenomas (PTA). Percutaneous ethanol ablation (PEI) has proven efficacy in the treatment of TA and is widely available in Europe, but not so in the USA. Methods: Retrospective analysis of all patients who underwent PEI for TA/PTA at the University of Utah, from January 2010 to 2018 was performed. Ultrasound guided PEI, with injections targeting power Doppler mapped blood vessels within the adenomas was conducted. Functionality was confirmed using thyroid scintigraphy prior to PEI. Results: Eighteen adults (15 female) underwent PEI. Mean age was 41 ± 13.7 years. Baseline TSH was suppressed (0.06 ± 0.09 mU/L) with normal FT4 1.43 ± 0.39 ng/dL. Median nodule volume was 5.7 cm3 (IQR 4.8-7.7 cm3). 78% (n=14) underwent 2 or less PEI sessions. Median volume of ethanol used was 0.46 ml/ml nodule volume (IQR 0.3-0.6 ml). There was a significant increase in TSH concentrations within the first 3 months after PEI (TSH 0.06 ± 0.09 mU/L vs 1.22 ± 1.88 mU/L; p=0.02) with a concomitant significant decrease in FT4 concentrations (FT4 1.43 ± 0.39 vs 1.13 ± 0.25 ng/d; p<0.01). Significant nodular volume reduction was observed following PEI [median 5.7 cm3 (IQR 4.8-7.7 cm3) vs 2.5 cm3 (IQR 2.0-7.8 cm3); p<0.01]. Conclusion: Vascularity targeted PEI is safe and effective for treating PTA and TA. This unique approach required lower injected alcohol volume and fewer injections for therapeutic success.